Regeneron · 4 months ago
Director, Health Economics & Outcomes Research- Hematology Oncology
SLEEPY HOLLOW
Full-time
Onsite
Director/Executive
$202K/yr - $337K/yr
7+ years expRegeneron Pharmaceuticals is seeking a strategic leader to join their Global HEOR team focusing on hematologic oncology. This role involves developing HEOR strategies, collaborating with cross-functional partners, and communicating insights to international teams to enhance patient access to novel therapies.
BiopharmaBiotechnologyPharmaceutical
Responsibilities
Developing and implementing global HEOR strategies for our leading hematologic oncology assets
Collaborating with cross-functional partners to strengthen product value propositions and support patient access
Leading design and execution of health economic models, value dossiers, and HTA submissions
Coordinating regulatory-grade real-world evidence studies and innovative RWD partnerships
Guiding development and validation of clinical outcomes assessments for integration into trials
Driving epidemiology analyses and observational studies to support development and commercial goals
Communicating HEOR insights to international teams, HTA bodies, and reimbursement decision-makers
Leading vendors and external experts to ensure high-quality HEOR results
Qualification
Required
Advanced graduate degree (Ph.D., MS, MD, PharmD, B. Pharm, or RN with master's) in a HEOR-related subject area such as health economics, outcomes research, health services research, pharmacoepidemiology, epidemiology, or statistics
7+ years of HEOR or related experience with a PhD, or 9+ years with an MS
Expertise in study design, health economic modeling, and COA development
Experience engaging with regulatory authorities and HTA agencies
Strong publication record
Oncology HEOR experience (minimum 2 years)
Familiarity with regulatory-grade RWE
Preferred
Oncology HEOR experience (minimum 2 years)
Familiarity with regulatory-grade RWE
Benefits
Health and wellness programs
Fitness centers
Equity awards
Annual bonuses
Paid time off
Company
Regeneron
Regeneron Pharmaceuticals specializes in the discovery, development, and commercialization of innovative medicines.
10001+ employees
H1B Sponsorship
Regeneron has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (157)
2024 (128)
2023 (128)
2022 (137)
2021 (104)
2020 (122)
Funding
Current Stage
Public CompanyTotal Funding
$15.93MKey Investors
U.S. Department of Health & Human Services
2024-07-11Post Ipo Equity· $2.03M
2023-10-18Post Ipo Equity· $5M
2016-08-22Post Ipo Equity· $8.9M
Leadership Team
Aris Baras
Senior Vice President, Regeneron Pharmaceuticals, General Manager, Regeneron Genetics Center
Bari Kowal
Senior Vice President, Head Development Operations & Portfolio Management
Recent News
Pharmaceutical Technology
2026-01-16
2026-01-16
Company data provided by crunchbase